Essel Propack - Packaging That World Prefers
![]()
It’s an everyday experience that an attractive packing attracts your attention even before you know its contents. Needless to say packing products and packaging industry is very much in demand from almost all the industries that are there. Essel Propack (EPL) needs no introduction as it is a global leader in laminated tubes domain with a 23 state-of-the-art facilities in 12 countries.
EPL enjoys a global clientele that includes Fortune 500 companies as well. At EPL, a number of joint development programs are run with various Indian and international strategic part-ners to achieve and promote innovative product development. Laminated tubes, plastic tubes, caps and closures are some of the prominent products from its wide range of products.
The continuous pursuing of improvement in existing technologies, products and process as well as discovery of new ones has taken EPL to its today’s position of the global leader in its domain of activities. Its lateral as well as vertical growth makes it easy for the successful execution of the expansion and innovation programs it undertakes. Equipped with the latest technology, its 23 facilities across 12 countries all over the world, EPL makes the best of the technological advances that take place in advanced countries, and integrate the same with upgrading of its processes and systems in its facilities. The true beneficiary of this feature is the happy customer who gets the best possible product from EPL. Let’s take a look at how Essel Propack is doing these days.
- Essel propack (EPL) has reported a good performance in Q2FY11. It has achieved a revenue growth at 19.4 per cent YoY to Rs 3.7 billion.
- EPL’s EBITDA margins at 18.5 per cent are highest in last 16 quarters and since EPL goes international.
- Essel Propack’s progress in various geographies was on expected lines - with Amesa and EAP reported strong traction in the quarter and Americas and Europe reporting reduction of EBIT loss.
So, what do these signs indicate for an investor? The company’s consolidated topline has suffered due to disposal of the company’s medical devices business. The company has also faced problem as a result of slowdown in Americas and in Europe. However, things are looking up now with the company expecting growth across geographies and improvement in the profitability of its European business. Moreover, the company is changing its products mix and increasing focus on cosmetic, hair care and pharmaceutical segment.